Evidence map›Paper›PMID 30297789›Full record

ArticleNature communications2018

Typing tumors using pathways selected by somatic evolution.

Sheng Wang, Jianzhu Ma, Wei Zhang, John Paul Shen, Justin Huang, Jian Peng, Trey Ideker

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multi-omics peripheral and core regions of cancer.NPJ systems biology and applications · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. NECo: A node embedding algorithm for multiplex heterogeneous networks.Proceedings. IEEE International Conference on Bioinformatics and Biomedicine · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sheng WangDepartment of Computer Science, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA.
Jianzhu MaDepartment of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.ORCID http://orcid.org/0000-0002-8236-6609
Wei ZhangDepartment of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
John Paul ShenDepartment of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Justin HuangDepartment of Medicine, University of California San Diego, La Jolla, CA, 92093, USA.
Jian PengDepartment of Computer Science, University of Illinois at Urbana-Champaign, Urbana, IL, 61801, USA. jianpeng@illinois.edu.
Trey IdekerDepartment of Medicine, University of California San Diego, La Jolla, CA, 92093, USA. tideker@ucsd.edu.ORCID http://orcid.org/0000-0002-1708-8454
National Foundation for Cancer Research · USUniversity of Illinois Urbana-Champaign · US

Funding

TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
Using Networks to Seed Hierarchical Whole-cell Models of CancerU54CA209891 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ASHWORTH, ALAN · 2017 to 2021
$10.9M
TRAININGU54GM114838 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI HAN, JIAWEI, SINHA, SAURABH · 2014 to 2017
$10.8M
Cytoscape: A Modeling Platform for Biomolecular NetworksR01HG009979 · NHGRI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2017 to 2021
$3.5M
NCI NIH HHS U54 CA209891NHGRI NIH HHS R01 HG009979NIGMS NIH HHS P41 GM103504NIGMS NIH HHS U54 GM114838
6 · The paper itself

Abstract

Many recent efforts to analyze cancer genomes involve aggregation of mutations within reference maps of molecular pathways and protein networks. Here, we find these pathway studies are impeded by molecular interactions that are functionally irrelevant to cancer or the patient's tumor type, as these interactions diminish the contrast of driver pathways relative to individual frequently mutated genes. This problem can be addressed by creating stringent tumor-specific networks of biophysical protein interactions, identified by signatures of epistatic selection during tumor evolution. Using such an evolutionarily selected pathway (ESP) map, we analyze the major cancer genome atlases to derive a hierarchical classification of tumor subtypes linked to characteristic mutated pathways. These pathways are clinically prognostic and predictive, including the TP53-AXIN-ARHGEF17 combination in liver and CYLC2-STK11-STK11IP in lung cancer, which we validate in independent cohorts. This ESP framework substantially improves the definition of cancer pathways and subtypes from tumor genome data.

Indexed as

MutationClonal EvolutionGene Expression Regulation, NeoplasticGenome, HumanHumansLiver NeoplasmsLung NeoplasmsNeoplasmsProtein Interaction MapsSignal Transduction

Identifiers

PMID30297789
PMCPMC6175900
OpenAlexW2894795605

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.